This helps us understand your health history, goals, and whether our program is a good fit for you
Why approval matters: Tesamorelin has completed rigorous Phase 3 clinical trials with documented efficacy data, comprehensive safety profiling, established adverse event profile, known contraindications, and monitoring requirements
If an abnormally high cumulative doses are administered, or the patient has low plasma pseudocholinesterase activity, then Phase I block can progress into Phase II block due to the inclusion of additional mechanisms that come into play when high synaptic levels of succinylcholine are achieved
The FDA has said it was evaluating other possible side effects for the drug, including hair loss and aspiration, while some complaints suggest it could cause digestive issues like stomach paralysis, pancreatitis and bowel obstructions
this might apply to other protozoal infections